Published in AIDS on May 07, 1999
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76
HIV infection and the risk of cancers with and without a known infectious cause. AIDS (2009) 3.13
Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr (2008) 2.44
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Br J Cancer (2006) 1.53
Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS (2011) 1.52
The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One (2010) 1.34
Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer (2003) 1.32
Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J Transl Med (2008) 1.28
Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS (2009) 1.22
HIV infection in the etiology of lung cancer: confounding, causality, and consequences. Proc Am Thorac Soc (2011) 1.13
Lung cancer in HIV infected patients: facts, questions and challenges. Thorax (2006) 1.13
Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS (2009) 1.12
Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol (2012) 1.02
An ecological approach to examine lung cancer disparities due to sexual orientation. Public Health (2012) 0.97
Do antiretrovirals reduce the risk of non-AIDS-defining malignancies? Curr Opin HIV AIDS (2009) 0.88
The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry. AIDS (2011) 0.87
Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant (2009) 0.86
HIV/AIDS and Colorectal Cancer: A Review in the Era of Antiretrovirals. Gastroenterol Hepatol (N Y) (2008) 0.85
Season of birth and risk for adult onset glioma. Int J Environ Res Public Health (2010) 0.83
Management of patients with HIV in the intensive care unit. Proc Am Thorac Soc (2006) 0.82
The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort study. BMJ Open (2012) 0.81
Sarcomas other than Kaposi sarcoma occurring in immunodeficiency: interpretations from a systematic literature review. Curr Opin Oncol (2012) 0.79
Prevalence and mortality of cancer among HIV-infected inpatients in Beijing, China. BMC Infect Dis (2016) 0.79
Survival and Prognostic Factors for AIDS and Non-AIDS Patients with Non-Hodgkin's Lymphoma in Bahia, Brazil: A Retrospective Cohort Study. ISRN Hematol (2013) 0.78
Human immunodeficiency virus-associated lung malignancies. Clin Chest Med (2013) 0.78
Non-AIDS-Defining Cancers and HIV Infection. Curr Infect Dis Rep (2005) 0.77
A Review of Carcinomas Arising in the Head and Neck Region in HIV-Positive Patients. Patholog Res Int (2011) 0.77
The association of neoplasms and HIV infection in the correctional setting. Int J STD AIDS (2004) 0.76
Incidence and risk of lung cancer in HIV-infected patients. J Cancer Res Clin Oncol (2013) 0.76
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat (2006) 5.10
Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med (1997) 3.44
Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS (1999) 3.28
Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet (1997) 2.97
Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology (2001) 2.90
Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. BMJ (1992) 2.68
Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ (1998) 2.64
The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel. J Med Genet (2004) 2.33
Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepat (2009) 2.18
Membrane tension in swelling and shrinking molluscan neurons. J Neurosci (1998) 2.18
HIV disease progression in Australia in the time of combination antiretroviral therapies. Med J Aust (1998) 2.16
Trends in infectious disease mortality in Australia, 1979-1994. Med J Aust (1998) 2.02
Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8. J Natl Cancer Inst Monogr (1998) 2.01
Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ (1997) 1.92
Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Collaboration of Australian NSPs. Med J Aust (2000) 1.92
Regional differences in the delayed rectifier current (IKr and IKs) contribute to the differences in action potential duration in basal left ventricular myocytes in guinea-pig. Cardiovasc Res (1998) 1.91
Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis (1997) 1.90
The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Med J Aust (1999) 1.85
The role of initial AIDS-defining illness in survival following AIDS. AIDS (1995) 1.82
Acquired immunodeficiency without evidence of HIV infection: national retrospective survey. BMJ (1994) 1.78
Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet (1999) 1.74
Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. Br J Cancer (1988) 1.74
Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS (2001) 1.72
How many dependent heroin users are there in Australia? Med J Aust (2000) 1.71
Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV-negative homosexual men: the Health in Men Study. Sex Transm Infect (2006) 1.59
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Perinatal exposure to HIV in Australia, 1982-1994. Med J Aust (1997) 1.54
Survival analyses of randomized clinical trials adjusted for patients who switch treatments. Stat Med (1996) 1.54
Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994. Am J Epidemiol (1997) 1.52
Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. Med J Aust (2000) 1.50
Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis. Bone (2011) 1.48
Nosocomial outbreak of tuberculosis in an outpatient HIV treatment room. AIDS (1996) 1.46
Oral contraceptives and breast cancer: a national study. Br Med J (Clin Res Ed) (1986) 1.44
Association between HIV distal symmetric polyneuropathy and Mycobacterium avium complex infection. J Neurol Neurosurg Psychiatry (1996) 1.44
Detection of HCV RNA in semen. Lancet (2000) 1.41
Use of interventions for reducing mother-to-child transmission of HIV in Australia. Med J Aust (2001) 1.40
Sexually transmissible diseases surveillance in Australia: towards a coordinated national system. Commun Dis Intell (1998) 1.40
Premature mortality in Australia 1983-1992, the first decade of the AIDS epidemic. Med J Aust (1995) 1.40
Allelotype of human bladder cancer. Cancer Res (1994) 1.38
Reporting of occupational exposures to blood-borne pathogens in Australian teaching hospitals. Med J Aust (1995) 1.38
Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer (1987) 1.37
Prior antiretroviral therapy experience protects against zidovudine-related anaemia. HIV Med (2007) 1.36
Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C. Clin Infect Dis (2011) 1.32
A national surveillance system for newly acquired HIV infection in Australia. National HIV Surveillance Committee. Am J Public Health (1994) 1.32
Cancer incidence in Asian migrants to New South Wales, Australia. Br J Cancer (1995) 1.31
Circumcision and male-to-male sexual transmission of HIV. AIDS (2001) 1.30
Kaposi's sarcoma and protection from AIDS dementia complex. AIDS (1998) 1.30
Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database. HIV Med (2007) 1.29
HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges. Med J Aust (1997) 1.26
HIV and AIDS in the Asia-Pacific region: an epidemiological overview. AIDS (1998) 1.24
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Predictors of recent HIV testing in homosexual men in Australia. HIV Med (2002) 1.23
High incidence of hepatitis C virus reinfection within a cohort of injecting drug users. J Viral Hepat (2007) 1.23
Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users. J Viral Hepat (2010) 1.23
The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev (1992) 1.23
HIV surveillance in hard-to-reach populations. AIDS (2001) 1.22
B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS (2000) 1.20
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Hepatitis B virus markers in children and staff in Northern Territory schools. Med J Aust (1992) 1.18
Self-report is a valid measure of circumcision status in homosexual men. Sex Transm Infect (2008) 1.18
Modulation of T-cell responses to alloantigens by TR6/DcR3. J Clin Invest (2001) 1.16
Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide. Br J Cancer (1987) 1.15
hERG channel trafficking: novel targets in drug-induced long QT syndrome. Biochem Soc Trans (2007) 1.12
Physiological role of Ca(2+)-activated and voltage-dependent K+ currents in rabbit coronary myocytes. Am J Physiol (1994) 1.11
Rat intestinal mucosal responses to a microbial flora and different diets. Gut (1995) 1.10
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Magnetic resonance thermometry during hyperthermia for human high-grade sarcoma. Int J Radiat Oncol Biol Phys (1998) 1.10
HIV and tuberculosis in rural sub-Saharan Africa: a cohort study with two year follow-up. Trans R Soc Trop Med Hyg (1999) 1.09
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Lifetime cost of human immunodeficiency virus-related health care. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.08
Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia. HIV Med (2009) 1.08
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Expression of PTEN and PTEN pseudogene in endometrial carcinoma. Int J Mol Med (2000) 1.07
Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991. Cancer Epidemiol Biomarkers Prev (1997) 1.06
Cancer incidence in migrants to New South Wales (Australia) from the Middle East, 1972-91. Cancer Causes Control (1994) 1.06
Fusing EEG and fMRI based on a bottom-up model: inferring activation and effective connectivity in neural masses. Philos Trans R Soc Lond B Biol Sci (2005) 1.05
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972-91. Cancer Causes Control (1996) 1.04
Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users. Epidemiol Infect (2006) 1.04
Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment. HIV Med (2007) 1.04
Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas. Br J Cancer (1994) 1.03
Socioeconomic differentials in cancer incidence and mortality in urban New South Wales, 1987-1991. Aust N Z J Public Health (1996) 1.02
Cancer mortality in East and Southeast Asian migrants to New South Wales, Australia, 1975-1995. Br J Cancer (1999) 1.02
Antiproliferation and apoptosis induction of paeonol in human esophageal cancer cell lines. Dis Esophagus (2008) 1.01
HIV prevalence at reception into Australian prisons, 1991-1997. Med J Aust (1999) 1.01
Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study. Drug Alcohol Depend (2010) 1.01
The Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) study: 2-year nonvertebral fragility fracture results. Osteoporos Int (2013) 1.00
Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. Curr Mol Med (2012) 1.00